Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 11:14 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 159 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Blood Loss, Surgical Clear all

Conditions: Blood Loss, Surgical, Prostate Cancer, Surgery
Interventions: Hemospan (MP4OX), Ringer's lactate; Drug
Lead sponsor: Sangart; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Postoperative Hemorrhage
Interventions: Fibrocaps (fibrin sealant), Gelfoam; Device
Lead sponsor: Mallinckrodt; Industry
Eligibility: 18 Years and older
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Vitreous Hemorrhage
Interventions: Intravitreal Aflibercept Injection, Standard Vitrectomy; Drug · Other
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Abdomen Hernia
Interventions: Prevena, Prineo, Traditional; Device · Drug
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2028
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Intracerebral Hemorrhage
Interventions: Not listed
Lead sponsor: OSF Healthcare System; Other
Eligibility: 18 Years to 80 Years
Enrollment: 2 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Peoria, Illinois

Conditions: Hemorrhage
Interventions: Augment O2 Delivery by hemodynamic protocol, High Risk Surgery; Other · Procedure
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years to 80 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2008
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Heart Attack, Cardiac Arrest, Congestive Heart Failure, Atrial Fibrillation, Angina, Deep Vein Thrombosis, Pulmonary Embolism, Respiratory Arrest, Respiratory Failure, Pneumonia, Gastrointestinal Bleed, Stomach Ulcer, Delirium, Stroke, Nerve Injury, Surgical Wound Infection
Interventions: Not listed
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 73,952 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2020
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Intracerebral Hemorrhage, Cerebral Hemorrhage, Intracerebral Haemorrhage
Interventions: Early Surgical Hematoma Evacuation; Procedure
Lead sponsor: Nico Corporation; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2023
U.S. locations: 36
States / cities: Birmingham, Alabama • Phoenix, Arizona • Little Rock, Arkansas + 27 more

Conditions: Metrorrhagia, Pelvic Pain, Menorrhagia, Leiomyoma
Interventions: Myfembree Oral Product; Drug
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years and older · Female only
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 6
States / cities: Chicago, Illinois • Flossmoor, Illinois • Orland Park, Illinois + 1 more

Conditions: Congenital Bleeding Disorder, Haemophilia B
Interventions: nonacog beta pegol; Drug
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 13 Years to 70 Years · Male only
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 7
States / cities: Los Angeles, California • San Francisco, California • Washington D.C., District of Columbia + 4 more

Conditions: Blood Loss, Surgical
Interventions: Trasylol (Aprotinin, BAYA0128), Placebo; Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years and older
Enrollment: 104 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 12
States / cities: Atlanta, Georgia • Augusta, Georgia • Indianapolis, Indiana + 8 more

Conditions: Shoulder Arthritis, Blood Loss, Surgical, Tranexamic Acid Adverse Reaction
Interventions: Tranexamic Acid, Normal Saline; Drug
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: Not listed
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Coronary Artery Disease
Interventions: Not listed
Lead sponsor: Baylor Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 102 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Plano, Texas

Conditions: Blood Loss, Surgical, Blood Loss Anemia
Interventions: Tranexamic Acid; Drug
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years and older
Enrollment: 83 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Intraoperative Bleeding
Interventions: BioFoam Surgical Matrix, Gelfoam Plus; Device
Lead sponsor: CryoLife, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 2
States / cities: Palo Alto, California • Seattle, Washington

Conditions: Surgical Blood Loss, Spinal Surgery
Interventions: SISTER device; Device
Lead sponsor: University of Miami; Other
Eligibility: 22 Years to 99 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Cesarean Delivery Procedures
Interventions: Uterine drain for use in cesarean section; Device
Lead sponsor: Lucie Medical Inc; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Soft Tissue Surgical Bleeding
Interventions: Fibrin Sealant (FS) Grifols, Surgicel®; Biological · Device
Lead sponsor: Grifols Biologicals, LLC; Industry
Eligibility: Not listed
Enrollment: 327 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 17
States / cities: Florence, Alabama • Pasadena, California • Bridgeport, Connecticut + 13 more

Conditions: Vascular Surgical Bleeding
Interventions: Fibrin Sealant Grifols, Manual Compression; Biological · Procedure
Lead sponsor: Instituto Grifols, S.A.; Industry
Eligibility: Not listed
Enrollment: 225 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 27
States / cities: Florence, Alabama • Palo Alto, California • San Diego, California + 23 more

Conditions: Prevent Bleeding in Major Surgery
Interventions: human VWF/FVIII concentrate; Biological
Lead sponsor: Octapharma; Industry
Eligibility: 6 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 3
States / cities: Indianapolis, Indiana • Chapel Hill, North Carolina • Milwaukee, Wisconsin

Conditions: Postoperative Pain Control in Surgical Neonates
Interventions: Ketorolac, placebo; Drug
Lead sponsor: Nationwide Children's Hospital; Other
Eligibility: 1 Week to 3 Months
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2018
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Blood Loss, Surgical
Interventions: rThrombin, 1000 IU/mL; Biological
Lead sponsor: ZymoGenetics; Industry
Eligibility: Up to 17 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Hemorrhage
Interventions: Blood drainage post cardiac surgery; Device
Lead sponsor: Centese, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Stanford, California

Conditions: Hip Fractures, Surgical Blood Loss
Interventions: Tranexamic Acid, Placebo; Drug · Other
Lead sponsor: Good Samaritan Regional Medical Center, Oregon; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Corvallis, Oregon

Search by objective public record fields.

Safety Study of Hemospan® in Prostatectomy Patients

U.S. Study of Fibrocaps in Surgical Hemostasis

Aflibercept Injection for Proliferative Diabetic Retinopathy

The Effects of Post-Operative Interventions on Surgical Site Occurrences in AWR

Clinical Outcomes Following Parafascicular Surgical Evacuation of Intracerebral Hemorrhage: A Pilot Study

Pre-emptive Hemodynamic Optimization of High Risk Patients Undergoing Elective Major Surgical Procedures

Systematic Assessment and Targeted Improvement of Services Following Yearlong Surgical Outcomes Surveys

ENRICH: Early MiNimally-invasive Removal of IntraCerebral Hemorrhage (ICH)

Surgical Myomectomy Followed by Oral Myfembree Versus Standard of Care Trial (SOUL)

Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B

Study to Investigate the Effect of Aprotinin of Transfusion Requirements in Patients Undergoing Surgical Procedures for Lung or Esophageal Cancer

Effect of TXA on Blood Loss in Reverse Total Shoulder Arthroplasty

Comparing Blood Loss, RBC Transfusions and Inflammatory Marker Changes Among Methods of CPB

Oral and Intravenous Tranexamic Acid in Lumbar Spine Surgery

Adjunctive Application of BioFoam Surgical Matrix in Liver Surgery

Efficacy of Suction Enabled Retraction Device

KIRA Uterine Drain Device Evaluation- First-In- Human Study

Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) During Soft Tissue Open Surgeries

Safety and Efficacy Study of Fibrin Sealant Grifols as an Adjunct to Hemostasis During Peripheral Vascular Surgery

Wilate in Subjects With Von Willebrand Disease Who Undergo Surgery

The Use of Ketorolac in Surgical Neonates

Safety and Immunogenicity Study of Recombinant Thrombin (rThrombin) in Pediatric Participants

Experiences With Automated Surgical Drainage in Cardiac Surgery

Tranexamic Acid in Intertrochanteric and Subtrochanteric Femur Fractures